One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration
Sign Up to like & getrecommendations! Published in 2017 at "Ophthalmologica"
DOI: 10.1159/000461785
Abstract: Purpose: We compared 1-year outcomes of 1 + pro re nata (PRN) versus 3 + PRN of intravitreal aflibercept injection (IAI) for age-related macular degeneration (AMD). Methods: Forty-two eyes with naïve AMD received 3 +… read more here.
Keywords: age related; intravitreal aflibercept; aflibercept injection; year outcomes ... See more keywords
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Sign Up to like & getrecommendations! Published in 2021 at "BMC Ophthalmology"
DOI: 10.1186/s12886-021-02088-x
Abstract: Background The current study aimed to evaluate the efficacy of intravitreal aflibercept injections as the primary treatment for subfoveal/juxtafoveal myopic choroidal neovascularization (CNV) by using optical coherence tomography (OCT). Optical coherence tomography angiography (OCTA) was… read more here.
Keywords: myopic; treatment; group; intravitreal aflibercept ... See more keywords
Chorioretinal response to intravitreal aflibercept injection in acute central serous chorioretinopathy.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2019.12.08
Abstract: AIM To evaluate chorioretinal responses to intravitreal aflibercept injection (IAI) in patients with acute central serous chorioretinopathy (CSC). METHODS Seventy-one eyes from 71 patients with symptomatic CSC for less than six months were included. Thirty-five… read more here.
Keywords: group; central serous; intravitreal aflibercept; aflibercept injection ... See more keywords